<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The objective of this study was to assess the course over time of the Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence </plain></SENT>
<SENT sid="1" pm="."><plain>The method used was a retrospective analysis of the medical records of a patient series with a median follow-up of 25 months </plain></SENT>
<SENT sid="2" pm="."><plain>The study was undertaken in a university hospital foregut laboratory </plain></SENT>
<SENT sid="3" pm="."><plain>The progress of seven patients was followed through the sequence of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>They <z:hpo ids='HP_0000001'>all</z:hpo> underwent subsequent esophagectomy and were found to have intramucosal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>The main outcome measure was the time from the first diagnosis of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> to the development of low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> developed in a median of 24 months, high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> after a median of 33 months and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> after 36 months </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent esophagectomy with reconstruction and no patient has had a recurrence at a median follow-up of 25 months (range 10-204 months) </plain></SENT>
<SENT sid="8" pm="."><plain>Patients on Barrett's surveillance who develop early esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> did so within approximately 3 years after the diagnosis of non-dysplastic <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
</text></document>